Heading Health is a technology-based mental health platform.
Through teletherapy, telepsychiatry, and interventional treatments such as Spravato, transcranial magnetic stimulation, and intramuscular ketamine, Heading provides personalized treatment solutions that leverage a comprehensive toolkit to address longstanding and chronic mental health disorders such as treatment-resistant depression, anxiety, and PTSD.
Heading combines psychotherapy, psychiatry, nutrition, and interventional modalities – and had plans for psychedelic treatments in the works – to offer outcome-focused treatments.
The company is an insurance-based mental healthcare provider, with most patients paying for care in part or fully through insurance. For those without an insurance plan or those who opt not to use insurance, a payment plan is set up depending on the services required.
Key customers and partnerships
Heading Health partners with major insurance planners such as UnitedHealthcare, Atena, Medicare, and Humana.
Funding and financials
Heading Health’s latest round of funding was in June 2023, when it raised USD 4.5 million in a series A round led by JAM Fund and Gron Ventures.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.